Nielsen H, Dahlstrøm G, Feldt-Rassmussen U, Seerup K, Kemp E, Svehag S E
Scand J Urol Nephrol Suppl. 1980;54:141-4.
The present study was conducted to assess whether immune complex (IC) activity, measured by a complement consumption assay (CC) could be used to indicate a forthcoming rejection crisis in the early phase after renal transplantation. Complement factor B and C4 determinations by immunoassays were performed also. Consecutive specimens were drawn from each patient (n = 14) from zero to nineteen days after transplantation. In seven of the fourteen patients elevated levels of IC activity were demonstrated prior to transplantation. About three weeks later only 2 of the patients had demonstrable IC in circulation. Activated factor B (B) was found in 11 of the patients just before transplantation; however, only three of the patients were factor B positive nineteen days later. During the same observation time ten of the patients (71%) had indication of one or several rejection crises. With a few exceptions only minor individual fluctuation in C4 serum-concentrations were seen. It is concluded that circulating IC occurred in a rather high percentage of patients with glomerulonephritis or pyelonephritis and that IC determination by the CC assay had no value in the prediction or diagnosis of rejection episodes following renal allotransplantation.
本研究旨在评估通过补体消耗试验(CC)测定的免疫复合物(IC)活性是否可用于指示肾移植术后早期即将发生的排斥危机。还通过免疫测定法对补体因子B和C4进行了测定。从每位患者(n = 14)移植后0至19天连续采集标本。在14例患者中的7例中,移植前IC活性水平升高。大约三周后,只有2例患者循环中有可检测到的IC。在移植前,11例患者中发现有活化因子B(B);然而,19天后只有3例患者因子B呈阳性。在相同的观察期内,10例患者(71%)有一次或几次排斥危机的迹象。除少数例外,C4血清浓度仅出现轻微的个体波动。得出的结论是,相当高比例的肾小球肾炎或肾盂肾炎患者出现循环IC,并且通过CC试验测定IC在预测或诊断肾同种异体移植后的排斥反应方面没有价值。